Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer
ConclusionOur study revealed the metabolic heterogeneity in SCLC and identified four subtypes with distinct metabolic features. It indicates promising therapeutic and prognostic value that may guide treatment for SCLC. The subtype-specific clinical trials may be designed and would be instructive for drug development.
Source: Metabolomics - Category: Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Clinical Trials | Genetics | Immunotherapy | Lung Cancer | Small Cell Lung Cancer | Study